BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 23442417)

  • 1. Radiofrequency ablation: technical and clinical long-term outcomes for single hepatocellular carcinoma up to 30 mm.
    Brunello F; Cantamessa A; Gaia S; Carucci P; Rolle E; Castiglione A; Ciccone G; Rizzetto M
    Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):842-9. PubMed ID: 23442417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma.
    Okuwaki Y; Nakazawa T; Kokubu S; Hidaka H; Tanaka Y; Takada J; Watanabe M; Shibuya A; Minamino T; Saigenji K
    Am J Gastroenterol; 2009 Nov; 104(11):2747-53. PubMed ID: 19603009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma ≤3 cm. Results of a multicenter Italian survey.
    Pompili M; Saviano A; de Matthaeis N; Cucchetti A; Ardito F; Federico B; Brunello F; Pinna AD; Giorgio A; Giulini SM; De Sio I; Torzilli G; Fornari F; Capussotti L; Guglielmi A; Piscaglia F; Aldrighetti L; Caturelli E; Calise F; Nuzzo G; Rapaccini GL; Giuliante F
    J Hepatol; 2013 Jul; 59(1):89-97. PubMed ID: 23523578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiofrequency ablation of hepatocellular carcinoma as first-line treatment: long-term results and prognostic factors in 162 patients with cirrhosis.
    Lee DH; Lee JM; Lee JY; Kim SH; Yoon JH; Kim YJ; Han JK; Choi BI
    Radiology; 2014 Mar; 270(3):900-9. PubMed ID: 24475823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiofrequency ablation for single hepatocellular carcinoma 3 cm or less as first-line treatment.
    Gao J; Wang SH; Ding XM; Sun WB; Li XL; Xin ZH; Ning CM; Guo SG
    World J Gastroenterol; 2015 May; 21(17):5287-94. PubMed ID: 25954102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in hepatitis C patients with a single small hepatocellular carcinoma after radiofrequency ablation.
    Toshikuni N; Takuma Y; Goto T; Yamamoto H
    Hepatogastroenterology; 2012; 59(120):2361-6. PubMed ID: 23169175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy.
    Takahashi S; Kudo M; Chung H; Inoue T; Ishikawa E; Kitai S; Tatsumi C; Ueda T; Minami Y; Ueshima K; Haji S
    Oncology; 2007; 72 Suppl 1():98-103. PubMed ID: 18087189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation.
    Lencioni R; Cioni D; Crocetti L; Franchini C; Pina CD; Lera J; Bartolozzi C
    Radiology; 2005 Mar; 234(3):961-7. PubMed ID: 15665226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effectiveness of radiofrequency ablation for solitary small hepatocellular carcinoma: a retrospective analysis of 363 patients.
    Francica G; Saviano A; De Sio I; De Matthaeis N; Brunello F; Cantamessa A; Giorgio A; Scognamiglio U; Fornari F; Giangregorio F; Piscaglia F; Gualandi S; Caturelli E; Roselli P; Rapaccini GL; Pompili M
    Dig Liver Dis; 2013 Apr; 45(4):336-41. PubMed ID: 23245589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study.
    Peng ZW; Lin XJ; Zhang YJ; Liang HH; Guo RP; Shi M; Chen MS
    Radiology; 2012 Mar; 262(3):1022-33. PubMed ID: 22357902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of long-term supplementation with branched-chain amino acid granules in patients with hepatitis C virus-related hepatocellular carcinoma after radiofrequency thermal ablation.
    Nishikawa H; Osaki Y; Iguchi E; Koshikawa Y; Ako S; Inuzuka T; Takeda H; Nakajima J; Matsuda F; Sakamoto A; Henmi S; Hatamaru K; Ishikawa T; Saito S; Nasu A; Kita R; Kimura T
    J Clin Gastroenterol; 2013 Apr; 47(4):359-66. PubMed ID: 23090049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection, or radiofrequency ablation?
    Chan AC; Chan SC; Chok KS; Cheung TT; Chiu DW; Poon RT; Fan ST; Lo CM
    Liver Transpl; 2013 Apr; 19(4):411-9. PubMed ID: 23447460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
    Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
    J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis.
    N'Kontchou G; Mahamoudi A; Aout M; Ganne-Carrié N; Grando V; Coderc E; Vicaut E; Trinchet JC; Sellier N; Beaugrand M; Seror O
    Hepatology; 2009 Nov; 50(5):1475-83. PubMed ID: 19731239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma invading portal venous system in cirrhosis: long-term results of percutaneous radiofrequency ablation of both the nodule and portal vein tumor thrombus. A case control study.
    Giorgio A; Calisti G; Montesarchio L; Scognamiglio U; Matteucci P; Coppola C; Scarano F; Amendola F; Giorgio V
    Anticancer Res; 2014 Nov; 34(11):6785-90. PubMed ID: 25368292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome of cirrhotic patients with early hepatocellular carcinoma treated with ultrasound-guided percutaneous laser ablation: a retrospective analysis.
    Pacella CM; Francica G; Di Lascio FM; Arienti V; Antico E; Caspani B; Magnolfi F; Megna AS; Pretolani S; Regine R; Sponza M; Stasi R
    J Clin Oncol; 2009 Jun; 27(16):2615-21. PubMed ID: 19332729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of a 'popping' sound during percutaneous radiofrequency ablation for hepatocellular carcinoma.
    Fernandes ML; Lin CC; Lin CJ; Chen WT; Lin SM
    J Vasc Interv Radiol; 2010 Feb; 21(2):237-44. PubMed ID: 20031448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified cisplatin-based transcatheter arterial chemoembolization for large hepatocellular carcinoma: multivariate analysis of predictive factors for tumor response and survival in a 163-patient cohort.
    Yoon HM; Kim JH; Kim EJ; Gwon DI; Ko GY; Ko HK
    J Vasc Interv Radiol; 2013 Nov; 24(11):1639-46. PubMed ID: 23962438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors.
    Kim YS; Lim HK; Rhim H; Lee MW; Choi D; Lee WJ; Paik SW; Koh KC; Lee JH; Choi MS; Gwak GY; Yoo BC
    J Hepatol; 2013 Jan; 58(1):89-97. PubMed ID: 23023009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten-year survival of hepatocellular carcinoma patients undergoing radiofrequency ablation as a first-line treatment.
    Yang W; Yan K; Goldberg SN; Ahmed M; Lee JC; Wu W; Zhang ZY; Wang S; Chen MH
    World J Gastroenterol; 2016 Mar; 22(10):2993-3005. PubMed ID: 26973395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.